nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—Epirubicin—uterine cancer	0.25	0.519	CrCtD
Valrubicin—Doxorubicin—uterine cancer	0.232	0.48	CrCtD
Valrubicin—TOP2A—Epirubicin—uterine cancer	0.0769	0.433	CbGbCtD
Valrubicin—TOP2A—Etoposide—uterine cancer	0.0599	0.337	CbGbCtD
Valrubicin—Daunorubicin—Epirubicin—uterine cancer	0.0535	0.173	CrCrCtD
Valrubicin—Doxorubicin—Epirubicin—uterine cancer	0.0535	0.173	CrCrCtD
Valrubicin—Idarubicin—Epirubicin—uterine cancer	0.0535	0.173	CrCrCtD
Valrubicin—Daunorubicin—Doxorubicin—uterine cancer	0.0495	0.16	CrCrCtD
Valrubicin—Epirubicin—Doxorubicin—uterine cancer	0.0495	0.16	CrCrCtD
Valrubicin—Idarubicin—Doxorubicin—uterine cancer	0.0495	0.16	CrCrCtD
Valrubicin—TOP2A—Doxorubicin—uterine cancer	0.0409	0.23	CbGbCtD
Valrubicin—TOP2A—myometrium—uterine cancer	0.000844	0.168	CbGeAlD
Valrubicin—Doxorubicin—AKR1C3—uterine cancer	0.000792	1	CrCbGaD
Valrubicin—Pelvic pain—Medroxyprogesterone Acetate—uterine cancer	0.000678	0.0281	CcSEcCtD
Valrubicin—TOP2A—uterine cervix—uterine cancer	0.000657	0.131	CbGeAlD
Valrubicin—TOP2A—decidua—uterine cancer	0.000626	0.125	CbGeAlD
Valrubicin—TOP2A—endometrium—uterine cancer	0.000594	0.118	CbGeAlD
Valrubicin—TOP2A—mammalian vulva—uterine cancer	0.000575	0.114	CbGeAlD
Valrubicin—TOP2A—uterus—uterine cancer	0.000547	0.109	CbGeAlD
Valrubicin—Nocturia—Progesterone—uterine cancer	0.000491	0.0204	CcSEcCtD
Valrubicin—TOP2A—female gonad—uterine cancer	0.000448	0.0891	CbGeAlD
Valrubicin—TOP2A—vagina—uterine cancer	0.000445	0.0886	CbGeAlD
Valrubicin—Cystitis noninfective—Progesterone—uterine cancer	0.000445	0.0184	CcSEcCtD
Valrubicin—Cystitis—Progesterone—uterine cancer	0.000439	0.0182	CcSEcCtD
Valrubicin—Anorectal discomfort—Etoposide—uterine cancer	0.000426	0.0177	CcSEcCtD
Valrubicin—Bladder pain—Progesterone—uterine cancer	0.000411	0.0171	CcSEcCtD
Valrubicin—Cystitis noninfective—Medroxyprogesterone Acetate—uterine cancer	0.000403	0.0167	CcSEcCtD
Valrubicin—Cystitis—Medroxyprogesterone Acetate—uterine cancer	0.000398	0.0165	CcSEcCtD
Valrubicin—Bladder pain—Medroxyprogesterone Acetate—uterine cancer	0.000373	0.0155	CcSEcCtD
Valrubicin—Rectal tenesmus—Epirubicin—uterine cancer	0.00035	0.0145	CcSEcCtD
Valrubicin—Rectal tenesmus—Doxorubicin—uterine cancer	0.000324	0.0134	CcSEcCtD
Valrubicin—Irritability—Progesterone—uterine cancer	0.000315	0.0131	CcSEcCtD
Valrubicin—TOP2A—lymph node—uterine cancer	0.000288	0.0573	CbGeAlD
Valrubicin—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.000286	0.0119	CcSEcCtD
Valrubicin—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.000285	0.0118	CcSEcCtD
Valrubicin—Proctalgia—Epirubicin—uterine cancer	0.000278	0.0115	CcSEcCtD
Valrubicin—Dysuria—Progesterone—uterine cancer	0.000267	0.0111	CcSEcCtD
Valrubicin—Pollakiuria—Progesterone—uterine cancer	0.000264	0.0109	CcSEcCtD
Valrubicin—Hyperglycaemia—Progesterone—uterine cancer	0.000258	0.0107	CcSEcCtD
Valrubicin—Proctalgia—Doxorubicin—uterine cancer	0.000258	0.0107	CcSEcCtD
Valrubicin—Pneumonia—Progesterone—uterine cancer	0.000256	0.0106	CcSEcCtD
Valrubicin—Urinary tract infection—Progesterone—uterine cancer	0.000247	0.0103	CcSEcCtD
Valrubicin—Body temperature increased—Carboplatin—uterine cancer	0.000244	0.0101	CcSEcCtD
Valrubicin—Dysuria—Medroxyprogesterone Acetate—uterine cancer	0.000242	0.01	CcSEcCtD
Valrubicin—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.000239	0.00991	CcSEcCtD
Valrubicin—Anorectal discomfort—Epirubicin—uterine cancer	0.000239	0.0099	CcSEcCtD
Valrubicin—Local reaction—Epirubicin—uterine cancer	0.000236	0.00978	CcSEcCtD
Valrubicin—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.000233	0.00968	CcSEcCtD
Valrubicin—Oedema peripheral—Progesterone—uterine cancer	0.000225	0.00934	CcSEcCtD
Valrubicin—Urinary tract infection—Medroxyprogesterone Acetate—uterine cancer	0.000224	0.0093	CcSEcCtD
Valrubicin—Anorectal discomfort—Doxorubicin—uterine cancer	0.000221	0.00916	CcSEcCtD
Valrubicin—Local reaction—Doxorubicin—uterine cancer	0.000218	0.00905	CcSEcCtD
Valrubicin—Pelvic pain—Epirubicin—uterine cancer	0.000215	0.0089	CcSEcCtD
Valrubicin—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.000204	0.00846	CcSEcCtD
Valrubicin—Pelvic pain—Doxorubicin—uterine cancer	0.000198	0.00823	CcSEcCtD
Valrubicin—Flatulence—Progesterone—uterine cancer	0.000196	0.00813	CcSEcCtD
Valrubicin—Back pain—Progesterone—uterine cancer	0.000192	0.00798	CcSEcCtD
Valrubicin—TOP2A—Podofilox—Etoposide—uterine cancer	0.000192	0.136	CbGdCrCtD
Valrubicin—TOP2A—Teniposide—Etoposide—uterine cancer	0.000192	0.136	CbGdCrCtD
Valrubicin—Ill-defined disorder—Progesterone—uterine cancer	0.000185	0.00766	CcSEcCtD
Valrubicin—Anaemia—Progesterone—uterine cancer	0.000184	0.00763	CcSEcCtD
Valrubicin—Pneumonia—Dactinomycin—uterine cancer	0.000181	0.00751	CcSEcCtD
Valrubicin—Malaise—Progesterone—uterine cancer	0.000179	0.00744	CcSEcCtD
Valrubicin—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.000178	0.00737	CcSEcCtD
Valrubicin—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.000174	0.00723	CcSEcCtD
Valrubicin—Myalgia—Progesterone—uterine cancer	0.000169	0.00703	CcSEcCtD
Valrubicin—Chest pain—Progesterone—uterine cancer	0.000169	0.00703	CcSEcCtD
Valrubicin—Discomfort—Progesterone—uterine cancer	0.000167	0.00694	CcSEcCtD
Valrubicin—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000167	0.00694	CcSEcCtD
Valrubicin—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000167	0.00691	CcSEcCtD
Valrubicin—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000163	0.00674	CcSEcCtD
Valrubicin—Ageusia—Epirubicin—uterine cancer	0.000161	0.00668	CcSEcCtD
Valrubicin—TOP2A—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.000157	0.111	CbGdCrCtD
Valrubicin—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000153	0.00637	CcSEcCtD
Valrubicin—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000153	0.00637	CcSEcCtD
Valrubicin—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000152	0.00629	CcSEcCtD
Valrubicin—Ageusia—Doxorubicin—uterine cancer	0.000149	0.00618	CcSEcCtD
Valrubicin—Vasodilation procedure—Epirubicin—uterine cancer	0.000149	0.00616	CcSEcCtD
Valrubicin—Vasodilation—Epirubicin—uterine cancer	0.000149	0.00616	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000148	0.00614	CcSEcCtD
Valrubicin—Nocturia—Epirubicin—uterine cancer	0.000141	0.00584	CcSEcCtD
Valrubicin—Vasodilation—Doxorubicin—uterine cancer	0.000137	0.0057	CcSEcCtD
Valrubicin—Vasodilation procedure—Doxorubicin—uterine cancer	0.000137	0.0057	CcSEcCtD
Valrubicin—TOP2A—Methyltestosterone—Progesterone—uterine cancer	0.000137	0.0965	CbGdCrCtD
Valrubicin—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000134	0.00556	CcSEcCtD
Valrubicin—Feeling abnormal—Progesterone—uterine cancer	0.000134	0.00555	CcSEcCtD
Valrubicin—Gastrointestinal pain—Progesterone—uterine cancer	0.000133	0.00551	CcSEcCtD
Valrubicin—Pneumonia—Etoposide—uterine cancer	0.000131	0.00543	CcSEcCtD
Valrubicin—Ill-defined disorder—Dactinomycin—uterine cancer	0.00013	0.00541	CcSEcCtD
Valrubicin—Nocturia—Doxorubicin—uterine cancer	0.00013	0.0054	CcSEcCtD
Valrubicin—Anaemia—Dactinomycin—uterine cancer	0.00013	0.00539	CcSEcCtD
Valrubicin—Abdominal pain—Progesterone—uterine cancer	0.000128	0.00532	CcSEcCtD
Valrubicin—Body temperature increased—Progesterone—uterine cancer	0.000128	0.00532	CcSEcCtD
Valrubicin—Cystitis noninfective—Epirubicin—uterine cancer	0.000127	0.00529	CcSEcCtD
Valrubicin—Malaise—Dactinomycin—uterine cancer	0.000127	0.00526	CcSEcCtD
Valrubicin—Cystitis—Epirubicin—uterine cancer	0.000126	0.00523	CcSEcCtD
Valrubicin—Blood urea increased—Epirubicin—uterine cancer	0.000123	0.00511	CcSEcCtD
Valrubicin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000121	0.00503	CcSEcCtD
Valrubicin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00012	0.00499	CcSEcCtD
Valrubicin—Myalgia—Dactinomycin—uterine cancer	0.00012	0.00497	CcSEcCtD
Valrubicin—Discomfort—Dactinomycin—uterine cancer	0.000118	0.00491	CcSEcCtD
Valrubicin—Bladder pain—Epirubicin—uterine cancer	0.000118	0.00489	CcSEcCtD
Valrubicin—Cystitis noninfective—Doxorubicin—uterine cancer	0.000118	0.00489	CcSEcCtD
Valrubicin—Cystitis—Doxorubicin—uterine cancer	0.000117	0.00484	CcSEcCtD
Valrubicin—Asthenia—Progesterone—uterine cancer	0.000116	0.00483	CcSEcCtD
Valrubicin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000116	0.00482	CcSEcCtD
Valrubicin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000116	0.00482	CcSEcCtD
Valrubicin—Pruritus—Progesterone—uterine cancer	0.000115	0.00477	CcSEcCtD
Valrubicin—Blood urea increased—Doxorubicin—uterine cancer	0.000114	0.00473	CcSEcCtD
Valrubicin—Diarrhoea—Progesterone—uterine cancer	0.000111	0.00461	CcSEcCtD
Valrubicin—Bladder pain—Doxorubicin—uterine cancer	0.000109	0.00453	CcSEcCtD
Valrubicin—Dizziness—Progesterone—uterine cancer	0.000107	0.00445	CcSEcCtD
Valrubicin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000106	0.00438	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000105	0.00434	CcSEcCtD
Valrubicin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000104	0.00432	CcSEcCtD
Valrubicin—Vomiting—Progesterone—uterine cancer	0.000103	0.00428	CcSEcCtD
Valrubicin—Rash—Progesterone—uterine cancer	0.000102	0.00425	CcSEcCtD
Valrubicin—Dermatitis—Progesterone—uterine cancer	0.000102	0.00424	CcSEcCtD
Valrubicin—Headache—Progesterone—uterine cancer	0.000102	0.00422	CcSEcCtD
Valrubicin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000101	0.00418	CcSEcCtD
Valrubicin—TOP2A—Idarubicin—Epirubicin—uterine cancer	0.0001	0.0708	CbGdCrCtD
Valrubicin—TOP2A—Doxorubicin—Epirubicin—uterine cancer	0.0001	0.0708	CbGdCrCtD
Valrubicin—TOP2A—Daunorubicin—Epirubicin—uterine cancer	0.0001	0.0708	CbGdCrCtD
Valrubicin—Back pain—Etoposide—uterine cancer	9.84e-05	0.00408	CcSEcCtD
Valrubicin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	9.73e-05	0.00404	CcSEcCtD
Valrubicin—Nausea—Progesterone—uterine cancer	9.64e-05	0.004	CcSEcCtD
Valrubicin—Feeling abnormal—Dactinomycin—uterine cancer	9.46e-05	0.00392	CcSEcCtD
Valrubicin—Ill-defined disorder—Etoposide—uterine cancer	9.44e-05	0.00392	CcSEcCtD
Valrubicin—Anaemia—Etoposide—uterine cancer	9.41e-05	0.0039	CcSEcCtD
Valrubicin—Gastrointestinal pain—Dactinomycin—uterine cancer	9.38e-05	0.00389	CcSEcCtD
Valrubicin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	9.35e-05	0.00388	CcSEcCtD
Valrubicin—TOP2A—Daunorubicin—Doxorubicin—uterine cancer	9.28e-05	0.0655	CbGdCrCtD
Valrubicin—TOP2A—Idarubicin—Doxorubicin—uterine cancer	9.28e-05	0.0655	CbGdCrCtD
Valrubicin—TOP2A—Epirubicin—Doxorubicin—uterine cancer	9.28e-05	0.0655	CbGdCrCtD
Valrubicin—Rash—Medroxyprogesterone Acetate—uterine cancer	9.28e-05	0.00385	CcSEcCtD
Valrubicin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	9.27e-05	0.00384	CcSEcCtD
Valrubicin—Headache—Medroxyprogesterone Acetate—uterine cancer	9.22e-05	0.00382	CcSEcCtD
Valrubicin—Malaise—Etoposide—uterine cancer	9.18e-05	0.00381	CcSEcCtD
Valrubicin—Abdominal pain—Dactinomycin—uterine cancer	9.07e-05	0.00376	CcSEcCtD
Valrubicin—Body temperature increased—Dactinomycin—uterine cancer	9.07e-05	0.00376	CcSEcCtD
Valrubicin—TOP2A—Norethindrone—Progesterone—uterine cancer	8.91e-05	0.0629	CbGdCrCtD
Valrubicin—Nausea—Medroxyprogesterone Acetate—uterine cancer	8.74e-05	0.00363	CcSEcCtD
Valrubicin—Chest pain—Etoposide—uterine cancer	8.66e-05	0.00359	CcSEcCtD
Valrubicin—Discomfort—Etoposide—uterine cancer	8.56e-05	0.00355	CcSEcCtD
Valrubicin—Asthenia—Dactinomycin—uterine cancer	8.23e-05	0.00342	CcSEcCtD
Valrubicin—Diarrhoea—Dactinomycin—uterine cancer	7.85e-05	0.00326	CcSEcCtD
Valrubicin—Dysuria—Epirubicin—uterine cancer	7.66e-05	0.00318	CcSEcCtD
Valrubicin—Pollakiuria—Epirubicin—uterine cancer	7.56e-05	0.00314	CcSEcCtD
Valrubicin—Hyperglycaemia—Epirubicin—uterine cancer	7.39e-05	0.00306	CcSEcCtD
Valrubicin—Pneumonia—Epirubicin—uterine cancer	7.34e-05	0.00305	CcSEcCtD
Valrubicin—Vomiting—Dactinomycin—uterine cancer	7.3e-05	0.00303	CcSEcCtD
Valrubicin—Rash—Dactinomycin—uterine cancer	7.24e-05	0.003	CcSEcCtD
Valrubicin—Urinary tract infection—Epirubicin—uterine cancer	7.1e-05	0.00294	CcSEcCtD
Valrubicin—TOP2A—Levonorgestrel—Progesterone—uterine cancer	7.09e-05	0.05	CbGdCrCtD
Valrubicin—Dysuria—Doxorubicin—uterine cancer	7.08e-05	0.00294	CcSEcCtD
Valrubicin—Pollakiuria—Doxorubicin—uterine cancer	7e-05	0.0029	CcSEcCtD
Valrubicin—Haematuria—Epirubicin—uterine cancer	6.96e-05	0.00289	CcSEcCtD
Valrubicin—Feeling abnormal—Etoposide—uterine cancer	6.84e-05	0.00284	CcSEcCtD
Valrubicin—Hyperglycaemia—Doxorubicin—uterine cancer	6.83e-05	0.00283	CcSEcCtD
Valrubicin—Nausea—Dactinomycin—uterine cancer	6.82e-05	0.00283	CcSEcCtD
Valrubicin—Pneumonia—Doxorubicin—uterine cancer	6.79e-05	0.00282	CcSEcCtD
Valrubicin—Gastrointestinal pain—Etoposide—uterine cancer	6.79e-05	0.00282	CcSEcCtD
Valrubicin—Body temperature increased—Etoposide—uterine cancer	6.57e-05	0.00272	CcSEcCtD
Valrubicin—Abdominal pain—Etoposide—uterine cancer	6.57e-05	0.00272	CcSEcCtD
Valrubicin—Urinary tract infection—Doxorubicin—uterine cancer	6.57e-05	0.00272	CcSEcCtD
Valrubicin—Oedema peripheral—Epirubicin—uterine cancer	6.46e-05	0.00268	CcSEcCtD
Valrubicin—Haematuria—Doxorubicin—uterine cancer	6.44e-05	0.00267	CcSEcCtD
Valrubicin—Oedema peripheral—Doxorubicin—uterine cancer	5.97e-05	0.00248	CcSEcCtD
Valrubicin—Asthenia—Etoposide—uterine cancer	5.96e-05	0.00247	CcSEcCtD
Valrubicin—Pruritus—Etoposide—uterine cancer	5.88e-05	0.00244	CcSEcCtD
Valrubicin—Diarrhoea—Etoposide—uterine cancer	5.68e-05	0.00236	CcSEcCtD
Valrubicin—Flatulence—Epirubicin—uterine cancer	5.62e-05	0.00233	CcSEcCtD
Valrubicin—Back pain—Epirubicin—uterine cancer	5.52e-05	0.00229	CcSEcCtD
Valrubicin—Dizziness—Etoposide—uterine cancer	5.49e-05	0.00228	CcSEcCtD
Valrubicin—Ill-defined disorder—Epirubicin—uterine cancer	5.29e-05	0.0022	CcSEcCtD
Valrubicin—Vomiting—Etoposide—uterine cancer	5.28e-05	0.00219	CcSEcCtD
Valrubicin—Anaemia—Epirubicin—uterine cancer	5.27e-05	0.00219	CcSEcCtD
Valrubicin—Rash—Etoposide—uterine cancer	5.24e-05	0.00217	CcSEcCtD
Valrubicin—Dermatitis—Etoposide—uterine cancer	5.23e-05	0.00217	CcSEcCtD
Valrubicin—Headache—Etoposide—uterine cancer	5.2e-05	0.00216	CcSEcCtD
Valrubicin—Flatulence—Doxorubicin—uterine cancer	5.2e-05	0.00216	CcSEcCtD
Valrubicin—Malaise—Epirubicin—uterine cancer	5.14e-05	0.00213	CcSEcCtD
Valrubicin—Back pain—Doxorubicin—uterine cancer	5.11e-05	0.00212	CcSEcCtD
Valrubicin—Nausea—Etoposide—uterine cancer	4.93e-05	0.00205	CcSEcCtD
Valrubicin—Ill-defined disorder—Doxorubicin—uterine cancer	4.9e-05	0.00203	CcSEcCtD
Valrubicin—Anaemia—Doxorubicin—uterine cancer	4.88e-05	0.00202	CcSEcCtD
Valrubicin—Chest pain—Epirubicin—uterine cancer	4.86e-05	0.00201	CcSEcCtD
Valrubicin—Myalgia—Epirubicin—uterine cancer	4.86e-05	0.00201	CcSEcCtD
Valrubicin—Discomfort—Epirubicin—uterine cancer	4.8e-05	0.00199	CcSEcCtD
Valrubicin—Malaise—Doxorubicin—uterine cancer	4.76e-05	0.00197	CcSEcCtD
Valrubicin—Myalgia—Doxorubicin—uterine cancer	4.49e-05	0.00186	CcSEcCtD
Valrubicin—Chest pain—Doxorubicin—uterine cancer	4.49e-05	0.00186	CcSEcCtD
Valrubicin—Discomfort—Doxorubicin—uterine cancer	4.44e-05	0.00184	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Epirubicin—uterine cancer	4.24e-05	0.00176	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	3.92e-05	0.00163	CcSEcCtD
Valrubicin—Feeling abnormal—Epirubicin—uterine cancer	3.84e-05	0.00159	CcSEcCtD
Valrubicin—Gastrointestinal pain—Epirubicin—uterine cancer	3.81e-05	0.00158	CcSEcCtD
Valrubicin—Body temperature increased—Epirubicin—uterine cancer	3.68e-05	0.00153	CcSEcCtD
Valrubicin—Abdominal pain—Epirubicin—uterine cancer	3.68e-05	0.00153	CcSEcCtD
Valrubicin—Feeling abnormal—Doxorubicin—uterine cancer	3.55e-05	0.00147	CcSEcCtD
Valrubicin—Gastrointestinal pain—Doxorubicin—uterine cancer	3.52e-05	0.00146	CcSEcCtD
Valrubicin—Body temperature increased—Doxorubicin—uterine cancer	3.41e-05	0.00141	CcSEcCtD
Valrubicin—Abdominal pain—Doxorubicin—uterine cancer	3.41e-05	0.00141	CcSEcCtD
Valrubicin—Asthenia—Epirubicin—uterine cancer	3.34e-05	0.00139	CcSEcCtD
Valrubicin—Pruritus—Epirubicin—uterine cancer	3.29e-05	0.00137	CcSEcCtD
Valrubicin—Diarrhoea—Epirubicin—uterine cancer	3.19e-05	0.00132	CcSEcCtD
Valrubicin—Asthenia—Doxorubicin—uterine cancer	3.09e-05	0.00128	CcSEcCtD
Valrubicin—Dizziness—Epirubicin—uterine cancer	3.08e-05	0.00128	CcSEcCtD
Valrubicin—Pruritus—Doxorubicin—uterine cancer	3.05e-05	0.00126	CcSEcCtD
Valrubicin—Vomiting—Epirubicin—uterine cancer	2.96e-05	0.00123	CcSEcCtD
Valrubicin—Diarrhoea—Doxorubicin—uterine cancer	2.95e-05	0.00122	CcSEcCtD
Valrubicin—Rash—Epirubicin—uterine cancer	2.94e-05	0.00122	CcSEcCtD
Valrubicin—Dermatitis—Epirubicin—uterine cancer	2.93e-05	0.00122	CcSEcCtD
Valrubicin—Headache—Epirubicin—uterine cancer	2.92e-05	0.00121	CcSEcCtD
Valrubicin—Dizziness—Doxorubicin—uterine cancer	2.85e-05	0.00118	CcSEcCtD
Valrubicin—Nausea—Epirubicin—uterine cancer	2.77e-05	0.00115	CcSEcCtD
Valrubicin—Vomiting—Doxorubicin—uterine cancer	2.74e-05	0.00114	CcSEcCtD
Valrubicin—Rash—Doxorubicin—uterine cancer	2.72e-05	0.00113	CcSEcCtD
Valrubicin—Dermatitis—Doxorubicin—uterine cancer	2.71e-05	0.00113	CcSEcCtD
Valrubicin—Headache—Doxorubicin—uterine cancer	2.7e-05	0.00112	CcSEcCtD
Valrubicin—Nausea—Doxorubicin—uterine cancer	2.56e-05	0.00106	CcSEcCtD
